Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betadine pleurodesis for refractory pleural effusion
IRCT20220117053750N1Phase 2Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of povidone-iodine in pleural effusion, sponsored by Kerman University of Medical Sciences. Primary endpoints: Age, Sex and 6 more. Started Mar 2021; status: completed.
02
Drugs
povidone-iodine
03
Conditions
pleural effusion
Beyond the preview
Go deeper on IRCT20220117053750N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220117053750N1.